Molecular tumor board discussion: “Molecules” missed to discuss in the tumor board-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Molecular tumor board discussion: “Molecules” missed to discuss in the tumor board

Published:2023 Issue:2 Volume:6 Page:347-348
ISSN:2590-3233
Container-title:Cancer Research, Statistics, and Treatment
language:en
Short-container-title:

Author:

Maskomani Silambarasan¹

Affiliation:

1. Personalized Healthcare - Ecosystems Partner (Kerala Cluster), Roche Products India Private Ltd., India

Publisher

Medknow

Subject

Cancer Research,Oncology (nursing),Drug Guides,Oncology

Reference7 articles.

1. SMAD4:A case-based review of the literature and current treatment options;Shah;Cancer Res Stat Treat,2023

2. A grading system for invasive pulmonary adenocarcinoma:A proposal from the international association for the study of lung cancer pathology committee;Moreira;J Thorac Oncol,2020

3. SMAD4 mutation correlates with poor prognosis in non-small cell lung cancer;Wang;Lab Invest,2021

4. PIK3CA alterations in non-small cell lung carcinoma:A puzzle yet to be solved;Baa;Cancer Res Stat Treat,2021

5. Nuclear translocation of p85βpromotes tumorigenesis of PIK3CA helical domain mutant cancer;Hao;Nat Commun,2022

Cited by 1 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Authors’ reply to Maskomani;Cancer Research, Statistics, and Treatment;2023

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP